NIAGEN BIOSCIENCE INC (NAGE) Fundamental Analysis & Valuation

NASDAQ:NAGE • US1710774076

Current stock price

4.28 USD
+0.08 (+1.9%)
At close:
4.1705 USD
-0.11 (-2.56%)
Pre-Market:

This NAGE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. NAGE Profitability Analysis

1.1 Basic Checks

  • NAGE had positive earnings in the past year.
  • NAGE had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: NAGE reported negative net income in multiple years.
  • In multiple years NAGE reported negative operating cash flow during the last 5 years.
NAGE Yearly Net Income VS EBIT VS OCF VS FCFNAGE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M -20M -30M

1.2 Ratios

  • NAGE has a Return On Assets of 16.34%. This is amongst the best in the industry. NAGE outperforms 97.30% of its industry peers.
  • The Return On Equity of NAGE (22.71%) is better than 91.89% of its industry peers.
  • NAGE's Return On Invested Capital of 13.06% is amongst the best of the industry. NAGE outperforms 83.78% of its industry peers.
Industry RankSector Rank
ROA 16.34%
ROE 22.71%
ROIC 13.06%
ROA(3y)6.62%
ROA(5y)-11.53%
ROE(3y)7.97%
ROE(5y)-23.86%
ROIC(3y)N/A
ROIC(5y)N/A
NAGE Yearly ROA, ROE, ROICNAGE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • Looking at the Profit Margin, with a value of 13.43%, NAGE belongs to the top of the industry, outperforming 91.89% of the companies in the same industry.
  • The Operating Margin of NAGE (11.05%) is better than 75.68% of its industry peers.
  • NAGE has a Gross Margin of 64.28%. This is comparable to the rest of the industry: NAGE outperforms 48.65% of its industry peers.
  • NAGE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.05%
PM (TTM) 13.43%
GM 64.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.66%
GM growth 5Y1.55%
NAGE Yearly Profit, Operating, Gross MarginsNAGE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. NAGE Health Analysis

2.1 Basic Checks

  • NAGE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, NAGE has more shares outstanding
  • The number of shares outstanding for NAGE has been increased compared to 5 years ago.
  • NAGE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NAGE Yearly Shares OutstandingNAGE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
NAGE Yearly Total Debt VS Total AssetsNAGE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 7.25 indicates that NAGE is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 7.25, NAGE belongs to the best of the industry, outperforming 94.59% of the companies in the same industry.
  • There is no outstanding debt for NAGE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.25
ROIC/WACC1.44
WACC9.08%
NAGE Yearly LT Debt VS Equity VS FCFNAGE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 4.86 indicates that NAGE has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 4.86, NAGE belongs to the best of the industry, outperforming 89.19% of the companies in the same industry.
  • A Quick Ratio of 3.83 indicates that NAGE has no problem at all paying its short term obligations.
  • NAGE's Quick ratio of 3.83 is amongst the best of the industry. NAGE outperforms 83.78% of its industry peers.
Industry RankSector Rank
Current Ratio 4.86
Quick Ratio 3.83
NAGE Yearly Current Assets VS Current LiabilitesNAGE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. NAGE Growth Analysis

3.1 Past

  • NAGE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 80.00%, which is quite impressive.
  • Looking at the last year, NAGE shows a very strong growth in Revenue. The Revenue has grown by 29.95%.
  • NAGE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.91% yearly.
EPS 1Y (TTM)80%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)29.95%
Revenue growth 3Y21.56%
Revenue growth 5Y16.91%
Sales Q2Q%16.19%

3.2 Future

  • NAGE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 52.84% yearly.
  • The Revenue is expected to grow by 18.17% on average over the next years. This is quite good.
EPS Next Y67.17%
EPS Next 2Y57.9%
EPS Next 3Y52.84%
EPS Next 5YN/A
Revenue Next Year16.14%
Revenue Next 2Y15.35%
Revenue Next 3Y18.17%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
NAGE Yearly Revenue VS EstimatesNAGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
NAGE Yearly EPS VS EstimatesNAGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

More info and screens

Find the best growth stocksShow best growing peers

5

4. NAGE Valuation Analysis

4.1 Price/Earnings Ratio

  • NAGE is valuated rather expensively with a Price/Earnings ratio of 23.78.
  • NAGE's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of NAGE to the average of the S&P500 Index (24.75), we can say NAGE is valued inline with the index average.
  • The Price/Forward Earnings ratio is 14.22, which indicates a correct valuation of NAGE.
  • Based on the Price/Forward Earnings ratio, NAGE is valued a bit cheaper than the industry average as 72.97% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of NAGE to the average of the S&P500 Index (22.10), we can say NAGE is valued slightly cheaper.
Industry RankSector Rank
PE 23.78
Fwd PE 14.22
NAGE Price Earnings VS Forward Price EarningsNAGE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • NAGE's Enterprise Value to EBITDA ratio is in line with the industry average.
  • NAGE's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 25.94
EV/EBITDA 18.44
NAGE Per share dataNAGE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • NAGE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of NAGE may justify a higher PE ratio.
  • A more expensive valuation may be justified as NAGE's earnings are expected to grow with 52.84% in the coming years.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y57.9%
EPS Next 3Y52.84%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NAGE Dividend Analysis

5.1 Amount

  • NAGE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NAGE Fundamentals: All Metrics, Ratios and Statistics

NIAGEN BIOSCIENCE INC

NASDAQ:NAGE (3/30/2026, 8:19:38 PM)

Premarket: 4.1705 -0.11 (-2.56%)

4.28

+0.08 (+1.9%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)03-04
Earnings (Next)05-05
Inst Owners41.73%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner Change0.43%
Market Cap342.74M
Revenue(TTM)129.42M
Net Income(TTM)17.38M
Analysts85.45
Price Target13.87 (224.07%)
Short Float %10.54%
Short Ratio4.29
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)120.03%
Min EPS beat(2)33.69%
Max EPS beat(2)206.37%
EPS beat(4)4
Avg EPS beat(4)168.26%
Min EPS beat(4)33.69%
Max EPS beat(4)252.87%
EPS beat(8)8
Avg EPS beat(8)205.53%
EPS beat(12)12
Avg EPS beat(12)156.2%
EPS beat(16)14
Avg EPS beat(16)119.31%
Revenue beat(2)2
Avg Revenue beat(2)5.89%
Min Revenue beat(2)4.65%
Max Revenue beat(2)7.13%
Revenue beat(4)4
Avg Revenue beat(4)7.44%
Min Revenue beat(4)4.65%
Max Revenue beat(4)10.27%
Revenue beat(8)6
Avg Revenue beat(8)3.55%
Revenue beat(12)8
Avg Revenue beat(12)3.34%
Revenue beat(16)8
Avg Revenue beat(16)0.83%
PT rev (1m)-13.92%
PT rev (3m)-13.92%
EPS NQ rev (1m)31.26%
EPS NQ rev (3m)31.26%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-14.58%
Revenue NQ rev (3m)-14.58%
Revenue NY rev (1m)-3.51%
Revenue NY rev (3m)-3.51%
Valuation
Industry RankSector Rank
PE 23.78
Fwd PE 14.22
P/S 2.65
P/FCF 25.94
P/OCF 25.38
P/B 4.48
P/tB 4.84
EV/EBITDA 18.44
EPS(TTM)0.18
EY4.21%
EPS(NY)0.3
Fwd EY7.03%
FCF(TTM)0.16
FCFY3.85%
OCF(TTM)0.17
OCFY3.94%
SpS1.62
BVpS0.96
TBVpS0.89
PEG (NY)0.35
PEG (5Y)N/A
Graham Number1.97
Profitability
Industry RankSector Rank
ROA 16.34%
ROE 22.71%
ROCE 16.53%
ROIC 13.06%
ROICexc 51.69%
ROICexgc 69.75%
OM 11.05%
PM (TTM) 13.43%
GM 64.28%
FCFM 10.21%
ROA(3y)6.62%
ROA(5y)-11.53%
ROE(3y)7.97%
ROE(5y)-23.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.66%
GM growth 5Y1.55%
F-Score6
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 37.2%
Cap/Sales 0.23%
Interest Coverage 14296
Cash Conversion 89.54%
Profit Quality 76.01%
Current Ratio 4.86
Quick Ratio 3.83
Altman-Z 7.25
F-Score6
WACC9.08%
ROIC/WACC1.44
Cap/Depr(3y)23.87%
Cap/Depr(5y)27.87%
Cap/Sales(3y)0.19%
Cap/Sales(5y)0.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y67.17%
EPS Next 2Y57.9%
EPS Next 3Y52.84%
EPS Next 5YN/A
Revenue 1Y (TTM)29.95%
Revenue growth 3Y21.56%
Revenue growth 5Y16.91%
Sales Q2Q%16.19%
Revenue Next Year16.14%
Revenue Next 2Y15.35%
Revenue Next 3Y18.17%
Revenue Next 5YN/A
EBIT growth 1Y85.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year98.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.52%
OCF growth 3YN/A
OCF growth 5YN/A

NIAGEN BIOSCIENCE INC / NAGE Fundamental Analysis FAQ

What is the fundamental rating for NAGE stock?

ChartMill assigns a fundamental rating of 6 / 10 to NAGE.


Can you provide the valuation status for NIAGEN BIOSCIENCE INC?

ChartMill assigns a valuation rating of 5 / 10 to NIAGEN BIOSCIENCE INC (NAGE). This can be considered as Fairly Valued.


Can you provide the profitability details for NIAGEN BIOSCIENCE INC?

NIAGEN BIOSCIENCE INC (NAGE) has a profitability rating of 6 / 10.


What are the PE and PB ratios of NIAGEN BIOSCIENCE INC (NAGE) stock?

The Price/Earnings (PE) ratio for NIAGEN BIOSCIENCE INC (NAGE) is 23.78 and the Price/Book (PB) ratio is 4.48.


What is the expected EPS growth for NIAGEN BIOSCIENCE INC (NAGE) stock?

The Earnings per Share (EPS) of NIAGEN BIOSCIENCE INC (NAGE) is expected to grow by 67.17% in the next year.